My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 179

    1.

    Diagnostic performance and predictive value of rheumatoid factor, anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis.

    Fathi NA, Ezz-Eldin AM, Mosad E, Bakry RM, Hamed HB, Ahmed S, Mahmoud M, Rashed HA, Abdullah F.

    Int Arch Med. 2008 Oct 22;1(1):20.PMID: 18945361 [PubMed - in process]Related articlesFree article

    2.

    Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.

    Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.

    Ann Rheum Dis. 2006 Apr;65(4):453-8. Epub 2005 Sep 21.PMID: 16176994 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.

    Kapitány A, Szabó Z, Lakos G, Aleksza M, Végvári A, Soós L, Karányi Z, Sipka S, Szegedi G, Szekanecz Z.

    Isr Med Assoc J. 2008 Jan;10(1):32-6.PMID: 18300568 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Antibodies against cyclic citrullinated peptide are associated with the DRB1 shared epitope and predict joint erosion in rheumatoid arthritis.

    Kaltenhäuser S, Pierer M, Arnold S, Kamprad M, Baerwald C, Häntzschel H, Wagner U.

    Rheumatology (Oxford). 2007 Jan;46(1):100-4. Epub 2006 May 25.PMID: 16728439 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.

    Bang SY, Lee KH, Cho SK, Lee HS, Lee KW, Bae SC.

    Arthritis Rheum. 2010 Feb;62(2):369-77.PMID: 20112396 [PubMed - in process]Related articles

    6.

    Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis.

    Alexiou I, Germenis A, Ziogas A, Theodoridou K, Sakkas LI.

    BMC Musculoskelet Disord. 2007 Apr 20;8:37.PMID: 17448247 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.

    Innala L, Kokkonen H, Eriksson C, Jidell E, Berglin E, Dahlqvst SR.

    J Rheumatol. 2008 Jun;35(6):1002-8. Epub 2008 Apr 1.PMID: 18398946 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1]

    Correa PA, Tobón GJ, Citera G, Cadena J, Schneeberger E, Camargo JF, Maldonado-Cocco JA, Anaya JM.

    Biomedica. 2004 Jun;24(2):140-52. Review. Spanish. PMID: 15495594 [PubMed - indexed for MEDLINE]Related articles

    9.

    Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide.

    Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, Yago T, Kobashigawa T, Tokunaga K, Tsuchiya N, Kamatani N, Kotake S.

    Clin Exp Rheumatol. 2007 Mar-Apr;25(2):219-24.PMID: 17543145 [PubMed - indexed for MEDLINE]Related articles

    10.

    Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage.

    Meyer O, Combe B, Elias A, Benali K, Clot J, Sany J, Eliaou JF.

    Ann Rheum Dis. 1997 Nov;56(11):682-5.PMID: 9462172 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis.

    van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR.

    Arthritis Rheum. 2006 Apr;54(4):1117-21.PMID: 16572446 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.

    van der Helm-van Mil AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE.

    Arthritis Rheum. 2007 Feb;56(2):425-32.PMID: 17265477 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.

    Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.

    Scand J Rheumatol. 2008 May-Jun;37(3):183-7.PMID: 18465452 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients.

    Farouk HM, Mansour HE, Rahman SA, Mostafa AA, Shamy HA, Zarouk WA.

    Braz J Med Biol Res. 2009 Sep;42(9):831-8.PMID: 19738989 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.

    Serdaroğlu M, Cakirbay H, Değer O, Cengiz S, Kul S.

    Rheumatol Int. 2008 Aug;28(10):965-70. Epub 2008 Apr 17.PMID: 18418600 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Anti-cyclic citrullinated peptide antibody isotypes in rheumatoid arthritis: association with disease duration, rheumatoid factor production and the presence of shared epitope.

    Lakos G, Soós L, Fekete A, Szabó Z, Zeher M, Horváth IF, Dankó K, Kapitány A, Gyetvai A, Szegedi G, Szekanecz Z.

    Clin Exp Rheumatol. 2008 Mar-Apr;26(2):253-60.PMID: 18565246 [PubMed - indexed for MEDLINE]Related articles

    17.

    Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.

    Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V.

    Ann Rheum Dis. 2009 May;68(5):736-43. Epub 2008 Jul 17.PMID: 18635594 [PubMed - indexed for MEDLINE]Related articles

    18.

    The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.

    Liu X, Jia R, Zhao J, Li Z.

    J Rheumatol. 2009 Jun;36(6):1136-42. Epub 2009 May 15.PMID: 19447936 [PubMed - indexed for MEDLINE]Related articles

    19.

    Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.

    Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.

    Joint Bone Spine. 2009 May;76(3):248-53. Epub 2009 Feb 8.PMID: 19208451 [PubMed - indexed for MEDLINE]Related articles

    20.

    HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.

    Charpin C, Balandraud N, Guis S, Roudier C, Toussirot E, Rak J, Lambert N, Martin M, Reviron D, Roudier J, Auger I.

    Clin Exp Rheumatol. 2008 Jul-Aug;26(4):627-31.PMID: 18799094 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity

    You are here: NCBI > Literature > PubMed
    Write to the Help Desk